Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3255.00 | 3582.00 | 0.9087 | 0.8042 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2843.00 | 3582.00 | 0.7937 | 0.5596 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3587.00 | 3582.00 | 1.0014 | 1.0030 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 2500.00 | 1881.33 | 1760.00 | 3582.00 | 0.4914 | -0.0692 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 4018.00 | 3582.00 | 1.1217 | 1.2632 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2935.00 | 3582.00 | 0.8194 | 0.6140 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 2500.00 | 1881.33 | 2080.00 | 3582.00 | 0.5807 | 0.1141 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 2007.00 | 3582.00 | 0.5603 | 0.0721 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2021.00 | 3582.00 | 0.5642 | 0.0801 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 1989.00 | 3582.00 | 0.5553 | 0.0617 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3636.00 | 3582.00 | 1.0151 | 1.0325 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 2500.00 | 1881.33 | 1809.00 | 3582.00 | 0.5050 | -0.0413 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3524.00 | 3582.00 | 0.9838 | 0.9652 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3532.00 | 3582.00 | 0.9860 | 0.9700 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2681.00 | 3582.00 | 0.7485 | 0.4642 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2394.00 | 3582.00 | 0.6683 | 0.2962 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3852.00 | 3582.00 | 1.0754 | 1.1627 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3103.00 | 3582.00 | 0.8663 | 0.7137 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3524.00 | 3582.00 | 0.9838 | 0.9652 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3585.00 | 3582.00 | 1.0008 | 1.0018 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 5.00 | 3582.00 | 0.0014 | -0.9983 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 5.00 | 3582.00 | 0.0014 | -0.9983 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3334.00 | 3582.00 | 0.9308 | 0.8514 | |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1881.33 | 2174.00 | 3582.00 | 0.6069 | 0.1684 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 1807.00 | 3582.00 | 0.5045 | -0.0425 |